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Abstract
Purpose: To evaluate automated multicriteria optimization (MCO) – de-
signed for intensity modulated radiation therapy (IMRT), but invoked with
limited segmentation – to efficiently produce high quality 3D conformal treat-
ment (3D-CRT) plans.
Methods: Ten patients previously planned with 3D-CRT were replanned
with a low-segment inverse multicriteria optimized technique. The MCO-
3D plans used the same number of beams, beam geometry and machine
parameters of the corresponding 3D plans, but were limited to an energy of
6 MV. The MCO-3D plans were optimized using a fluence-based MCO IMRT
algorithm and then, after MCO navigation, segmented with a low number of
segments. The 3D and MCO-3D plans were compared by evaluating mean
doses to individual organs at risk (OARs), mean doses to combined OARs,
homogeneity indexes (HI), monitor units (MUs), physician preference, and
qualitative assessments of planning time and plan customizability.
Results: The MCO-3D plans significantly reduced the OAR mean doses and
monitor units while maintaining good coverage and homogeneity of target
volumes. MCO allows for more streamlined plan customization. All MCO-
3D plans were preferred by physicians over their corresponding 3D plans.
Conclusion: High quality 3D plans can be produced using IMRT optimiza-
tion technology, resulting in automated field-in-field type plans with good
monitor unit efficiency. Adopting this technology in a clinic could streamline
treatment plan production.
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1. Introduction
3D planning, also known as forward planning, is a standard approach for
delivering conformal radiotherapy to a variety of cancers. The simplicity,
low cost, low maintenance and well documented outcomes of 3D planning
have made it the preferred choice for many disease sites. In 3D planning,
dose distribution changes are made as a direct result of the planner manually
modifying various treatment parameters such as field shapes, beam weights,
beam modifiers, and dose normalization.
The 2000s saw a growing interest in intensity modulated radiation ther-
apy (IMRT), a computer optimized method of delivering radiation [1] which
modulates radiation from each field through the use of a multi-leaf collimator
(MLC), permitting greater conformality and better OAR sparing. However
IMRT comes with its own challenges including greater susceptibility to mo-
tion [2, 3], more complex dosimetry, potentially higher monitor units and
treatment time [4], increased quality assurance (QA) complexity and greater
machine wear-and-tear [5]. IMRT can cost anywhere from 1.5 to four times
the amount of a 3D plan [6, 7, 8], and resistance from insurance companies
to reimburse for IMRT adds to the persistence of 3D conformal therapy in
clinics worldwide (e.g. [9]). Some disease sites, notably prostate and head-
and-neck, have moved to IMRT planning for the majority of their cases, but
many common sites such as breast and lung remain in the 3D planning realm.
Due to the manual manipulation required in 3D planning it can be time-
consuming to find a desirable dose distribution. Also, once a plan is created
there is no way of confirming whether the plan is fully optimized. By ‘fully
optimized’ we refer to a plan where any improvement of one criteria – eg.
homogeneity or OAR dose – must come at the expense of worsening another
planning criteria. This requirement is known as Pareto optimality. The set
of Pareto optimal plans is called the Pareto surface and exploring this surface
has become a valuable technique for IMRT planning [10, 11]. MCO for IMRT
allows the planner to smoothly navigate through all the generated plans by
mixing individual plan fluences, allowing for a quick exploration of possible
plans. Comparison studies of MCO and standard planning for IMRT have
shown MCO can significantly minimize the time needed to generate a plan,
while producing plans preferred by the physicians [10].
Since Pareto navigation hinges on the ability to average multiple plans,
IMRT (as well as intensity modulated proton therapy) is an ideal modality
since fluence maps can be averaged, which leads to the averaging of dose dis-
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tributions. Because common 3D conformal sites only require a small amount
of intensity modulation, we hypothesized that using fluence map based MCO
and a low number of segments would allow us to use the MCO-IMRT plan-
ning technique to generate high quality 3D conformal plans. In this way,
we get the best of the two worlds: the relative simplicity of 3D plans with
the power of numerical optimization that comes with IMRT. Empowered by
an MCO Pareto surface, the planner and physician can rapidly explore dose
tradeoffs. Lastly, because we are using low segments, no physical wedges,
and an efficient optimizer, we reduce MUs, retain plan robustness, reduce
patient treatment time and reduce the need for patient-specific QA.
2. Methods and materials
2.1. Case selection and structure definitions
Ten recently planned patients of various disease sites (breast, brain, lung,
abdomen and pelvis) were selected from our institutional clinical database.
These sites were chosen to show the technique across a wide range of 3D
planned areas of the body.
The original physician-drawn target volumes and OARs as well as the
original dosimetrist-generated target expansion volumes were used to plan
and evaluate all plans. In the MCO-3D cases additional planning structures
were created to help guide the optimizer. Each MCO-3D plan contained
a structure expanded from the PTV radially to the edge of the CT scan
but only 4cm superiorly and inferiorly, effectively creating a wide cylindrical
volume. This structure was termed ‘falloff’ and was used to promote dose
conformality. Some MCO-3D plans used an additional 2-3cm wall expansion
around the PTV, called ‘PTVwall’, for additionally sharpening high-dose
conformality.
For the breast cases, the physician-drawn targets include only the breast
contour and the seroma. For planning purposes, an artificial PTV was cre-
ated by taking the breast contour and contracting it from the edge of the CT
scan by 2mm. This was to prevent the optimizer from aggressively trying to
deliver full dose near the patient’s skin.
For all patients we also created a structure called ‘total OAR’ which was
the union of all the OARs, in order to evaluate the overall mean dose to
OARs.
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2.2. Planning Parameters
XiO (v4.4; Elekta, Stockholm, Sweden) was used to plan and calculate
all original 3D plans. We selected recent plans from the clinical database,
thus the planning strategy for the 3D conformal plans was our standard
clinical procedure. RayStation (v2.5; RaySearch Laboratories, Stockholm,
Sweden) was used to optimize and calculate all MCO-3D plans. The MCO-
3D plans matched the original 3D plans in terms of machine (Varian or
Elekta), number of beams and beam geometry. The MCO-3D plans did not
use any beam modifiers (i.e. wedges), and were limited to an energy of 6
MV. All MCO-3D plans followed the original 3D plan prescription dose and
fractionation schemes.
Pareto surface-based MCO uses the classical optimization paradigm of
objectives and constraints. Constraints are criteria which cannot be violated
while objectives are functions which are minimized or maximized subject to
the constraints. All OARS were assigned a ‘minimize the equivalent uniform
dose (EUD)’ objective [12, 13]. EUD for an organ with n equi-sized voxels,
each receiving di dose, is given by
EUD =
(
1
n
∑
i
dai
)1/a
, (1)
where a is a parameter generally chosen to be greater than or equal to 1. If
a = 1, the EUD is the mean dose to the organ. As a is increased, the function
is weighted more heavily towards larger doses. In the limit of a → ∞, the
EUD approaches the maximum dose of the organ. The EUD is a convex
function which makes it appealing for optimization purposes. We use a = 2
which is a standard approach to controlling both the mean dose and the
hotspots.
For the falloff structure we use the ‘dose-falloff’ objective. This objective
penalizes doses outside the target by specifying a desired dose falloff rate (as
a function of distance to the target). Voxels which violate this dose falloff
are penalized quadratically based on their deviation.
In the cases where the PTVwall structure was used, this structure was
given an EUD objective with an a value ranging from 20-30 to penalize high
doses. The target volume (PTV in all cases) was given both objectives and
constraints. The target objectives consisted of a minimum dose objective,
which is a quadratic penalty on voxel underdosage, and a uniform dose ob-
jective (the standard two-sided quadratic penalty), both at the prescription
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dose. The target constraints included a dose-volume constraint of at least
95% of the volume receiving the prescription dose as well as a minimum tar-
get dose of 95% of the prescription. Lastly, a constraint was given on the
falloff volume as a max dose equal to 105% of the prescription dose. This
served to limit the global maximum dose of the plan.
Once the objectives and constraints are entered, RayStation computes a
set of Pareto optimal plans. This begins with anchor plans, which optimize
each objective individually, while respecting the constraints. Once all anchor
plans are generated, RayStation creates plans where two or more objectives
are simultaneously optimized. These auxiliary plans help to enrich the Pareto
surface for better navigation. The total number of plans computed is a user-
defined parameter. In this study we used 4N plans for each Pareto surface,
where N is the number of objectives defined. After navigation, RayStation’s
direct machine parameter optimization is invoked which creates a deliverable
plan. In this step the system determines MLC segment shapes and weights
to best create the navigated-to dose.
2.3. Determination of number of segments
Since the IMRT module of RayStation does not support higher energies
or wedges, we opted to allow the MCO-3D plans a few additional segments to
allow the MCO-3D plans to compete more fairly with the standard 3D con-
formal plans, which utilize wedges, higher energies, and field-in-fields (FIFs).
RayStation allows the planner to constrain the maximum number of segments
used for the segmentation of a fluence optimized plan, and it automatically
determines which beams will have additional segments, with the stipulation
that each beam gets at least one segment. We determined the number of
segments using the following:
1. One segment per unique beam angle in the original 3D plan
2. One segment per field-in-field used in the original 3D plan.
3. We add the number of fields using higher energies (HE) than 6 MV to
the number of wedges (W) used to get “HE+W”, then add additional
segments to the MCO-3D plan based on the following.
• If the HE+W = 1-2, we add 1 additional segment
• If the HE+W = 3-5, we add 2 additional segments
• If the HE+W = 6+, we add 3 additional segments
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2.4. Pareto surface navigation and final plan selection
Each MCO-3D plan was navigated to reduce OAR doses while meeting
one of the following criteria:
• the plan met or exceeded the original 3D plan’s coverage at prescription
dose
• 95% of the PTV volume received prescription dose (our clinical stan-
dard).
After navigation and segmentation, normalization (scaling) was used to achieve
coverage, if necessary.
2.5. Evaluation
Once all MCO-3D plans were completed they were evaluated for clinical
acceptability. We evaluated each plan by comparing individual OAR mean
dose, total OAR mean dose, MU and homogeneity indexes. The homogeneity
index (HI) is defined as:
HI =
D5 −D95
Dp
where D5 is the dose to 5% of the PTV, D95 is the dose to 95% of the PTV,
and Dp is the prescription dose. A perfectly homogeneous PTV dose would
have D5, which measures hotspots, equal to D95, which measures the cold
spots. Therefore the best achievable value for HI is 0.
All dose computations were done with the in-use clinically commissioned
systems. The original 3D plans and the MCO-3D plans were exported to
MimVista (Version 6.0, Cleveland, OH) for evaluation, in order to eliminate
inherent differences in DVH computations by the two planning systems.
3. Results
3.1. Case descriptions
We describe each case in terms of the site, prescription, beam energies
and geometries, and techniques used in the original 3D plan. For each case
we state any significant difference between the original 3D plan and the
MCO-3D plan regarding OAR sparing and homogeneity. We also indicate
any significant difficulties encountered in the MCO-3D planning including
hotspots occurring outside of the PTV, dose streaking, and maintaining an
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acceptable homogeneity index within the PTV. Dose and MU comparison
data for all cases are summarized in Table 1. We selected four of the cases
to display the dose distribution and DVH comparisons. We selected these to
show a range of results (we did not select the cases which yielded the ‘best’
results for the MCO-3D planning, we selected a representative set).
Brain cases
Case 1 was a posterior fossa tumor prescribed to 20 Gy. A 4 field X-
shaped beam arrangement was used. The original 3D plan utilized all 10
MV beams as well as four wedges and two FIFs. The only OARs drawn were
the cochleas. The MCO-3D spared both cochleas significantly more than the
original 3D plan and created a much steeper dose gradient outside the PTV.
This OAR sparing came at the price of a reduction in homogeneity, with an
HI of .07 compared to .03 for the original plan. The PTVwall structure was
helpful in controlling hotspots outside the PTV volume.
Case 2 was a left parietal tumor prescribed to 60 Gy. A 5-field beam
arrangement was used: four coplanar beams and one superior vertex beam.
The original 3D plan used 6 MV for all coplanar beams and 10 MV for
the superior vertex beam. Three wedges were also used. The most notable
sparing observed in the MCO-3D plan were in the chiasm, R. cochlea and
R. optic nerve; each of their mean doses were lowered by a factor of three.
There were very small increases in mean dose for the L. optic nerve and the
L. cochlea. As in brain case 1, this significant OAR sparing came at the
price of a small increase in the homogeneity index, from .04 to .06. The
comparison between the original 3D plan and the MCO-3D plan for brain
case 2 is shown in Figure 1.
Breast cases
Case 1 was a right sided breast to 50 Gy. This patient had a small
breast and the original 3D plan employed two open tangent 6 MV fields.
The HE+W number was zero, thus the MCO-3D plan utilized only two
segments total (one segment for each field). The MCO-3D plan was able to
drastically improve breast coverage at prescription dose (15% increase) while
simultaneously reducing lung dose. Hotspots and the global maximum were
kept nearly identical to the original 3D plan. The homogeneity index was
improved from .31 to .18, due to the increase in coverage without an increase
in hotspots.
Case 2 was a left sided breast, also to 50 Gy, which allowed us to test
our technique with a case involving the whole heart, left ventricle and left
7
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Figure 1: Axial dose distribution and DVH comparison for brain case 2. The red arrows
highlight MCO-3D pushing low dose away from critical organs.
anterior descending (LAD) artery in addition to the lung. The original 3D
plan utilized two open tangents and two field-in-fields. 10 MV was used
on the medial side while 6 MV was used on the lateral side. The plan’s
HE+W number was two, therefore we used one additional segment beyond
the original number of parent fields and FIFs, for a total of five segments.
Similar to case 1, the MCO-3D demonstrated superior breast coverage while
simultaneously lowering whole heart, left ventricle, LAD and lung dose. Once
again, hotspots remained similar to the original 3D plan and the homogeneity
index improved from .43 to .21. The plan comparison is shown in Figure 2.
Thoracic cases
Case 1, the most challenging of the ten cases, was a large lung volume with
a prescription dose of 42 Gy. The GTV was very extensive and branched into
many nodal chains throughout the thorax. The PTV volume was 957 cubic
centimeters. The original 3D plan used five coplanar fields – one anterior
and four obliques. 10 MV was used for all beams as well as four wedges.
The MCO-3D reduced every OAR at the expense of a small decrease in
homogeneity. The plan comparison is shown in Figure 3.
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Figure 2: Axial dose distribution and DVH comparison for breast case 2.
  
Original 3D
MCO-3D
Figure 3: Axial dose distribution and DVH comparison for thoracic case 1. The circled
regions indicate areas where MCO-3D clearly sculpts the dose distribution to conform to
the PTV.
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Case 2 was an esophagus prescribed to 55 Gy. The original plan employed
a four field posterio-lateral beam arrangement. Wedges and 10 MV beams
were used on all fields, leading to seven segments total for the MCO-3D plan.
The MCO-3D lowered the mean dose of every OAR although not as signifi-
cantly as in thoracic Case 1. There was no significant change in homogeneity
however MCO-3D did encounter difficulties with high dose building up near
the skin. A 2cm inner wall contour created from the external contour was
necessary to help control this.
Abdomen cases
Case 1 was a pancreas volume prescribed to a dose of 30 Gy. A 4-field
conformal beam arrangement was used. All beams were 15 MV and three
wedges were used in the original plan. The MCO-3D plan lowered the mean
dose of most OARs. The small bowel and R. kidney were lowered more
significantly while the spinal cord dose was increased. There was a small
homogeneity index increase for the MCO-3D plan, from .06 to .07.
Case 2 was a larger pancreas volume prescribed to 45 Gy. The original
3D plan used five beam angles, with 15 MV for all beams, and two wedges.
The MCO-3D significantly lowered all OAR mean doses. The homogeneity
index rose from .05 to .08. Initially, some dose streaking was encountered in
the MCO-3D plan. This case successfully showed MCO-3D’s ability to treat
larger and deeper seated abdominal volumes.
Pelvis cases
Case 1 was a standard four-field box prostate fossa prescribed to 64.8 Gy.
The original plan used 10 MV on all beams except the AP beam which used
6 MV. The bladder and rectum were spared very well in the MCO-3D plan.
Femoral head mean doses were also lower in the MCO-3D plan. Higher lat-
eral entrances doses occurred with the MCO-3D plan. Homogeneity indexes
remained the same as the original 3D plan. The comparison between the
original 3D plan and the MCO-3D plan for pelvis case 1 is shown in Figure
4.
Case 2 was a three-field bladder prescribed to 39.6 Gy. The original 3D
plan used two oblique laterals and one right anterior oblique beam. 10 MV
was used for all three fields and two wedges were also used. The MCO-3D
plan was able to reduce the mean dose to all OARs, especially the femoral
heads. No significant difficulties were encountered with the MCO-3D plan,
however the homogeneity index increase in this plan was the greatest, from
.05 to .09.
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Table 1: Dosimetric and monitor unit (MU) comparisons for all ten patient cases. For
OARS, mean dose in Gy is reported, and for the target, homogeneity index HI, as defined
in the text, is reported.
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Figure 4: Axial dose distribution and DVH comparison for pelvis case 1. The red arrows
show that the MCO-3D plans are able to push dose out of the rectum.
3.2. Summary of plan comparisons: doses, MUs, physician preference, and
planning
In every MCO-3D plan, the majority of OAR mean doses were lowered
compared to the original 3D plan. In some cases the MCO-3D plan gave one
or two OARs a greater mean dose, however this slight increase was overcome
by lowering others OARs even more. In the cases where some OARs are
lower while others are higher it can sometimes be difficult to evaluate whether
there was an overall improvement in mean OAR dose. In order to quantify
the overall reduction of mean dose to organs, we evaluated the mean dose to
the total OAR structure. In each case the MCO-3D had a lower total OAR
mean dose, see Table 1.
After all the MCO-3D plans were generated they were coupled with their
original 3D plan and sent back to the treating physician to ask which plan
they preferred. In all ten cases the physicians selected the MCO-3D plans
over the original 3D plans.
On average, fewer MUs were required by the MCO-3D plans. The average
MU of the original 3D plans was 313 while the average MU of the MCO-3D
plans was 259, a 17% decrease. This finding defeats the long held belief that
inverse planning necessarily produces greater MUs than forward 3D planning:
it depends on the number of segments being used. The brain cases had the
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most significant total reduction in MU, with a combined total of 284 fewer
MUs for MCO-3D. The least change in MU were in the breast cases.
Treatment planning times for our MCO-3D plans were similar to tradi-
tional 3D planning (although the bulk of the MCO-3D planning time was
used in computing Pareto surfaces, a process which has been improved in
later versions of RayStation, with more increases expected by moving to a
distributed computing environment [14]). The use of higher energy beams in
MCO-3D will also help the planning time by alleviating dose streaking and
improving homogeneity.
4. Discussion and Conclusions
Photon treatments are typically classified as either 3D conformal plans
or IMRT plans. It is more useful for understanding treatment plan opti-
mization to think of these modalities as lying along a continuous span of
treatment possibilities, from simple to complex [15]. Although somewhat
counterintuitive, IMRT treatment planning is sometimes easier than 3D con-
formal since numerical optimization can be used to find optimal solutions,
and planning software and computation power have improved dramatically
since the early days of IMRT. Considering this, we speculated that if IMRT
optimization was used – in particular MCO – we might be able to derive
good 3D solutions from the selected IMRT plan if that plan would naturally
not require too much intensity modulation. For example, IMRT optimization
applied to a spherical tumor might yield relatively flat beam profiles which
could then be delivered with open 3D conformal fields. In the ten cases we
examined, using the IMRT optimizer to produce 3D plans led to significant
OAR sparing at the cost of a small decrease in target homogeneity, and the
treating physicians unanimously preferred the MCO-3D plans to the original
3D plans.
A single treatment planning system used for both 3D conformal planning
and IMRT planning would be beneficial from a training and quality assur-
ance perspective. Fewer systems means an overall operation that is easier to
monitor and less prone to error [16, 17].
While this is not the place for a full discussion of the insurance and
billing differences between 3D and IMRT, which is related to the historical
difficulty of planning and delivering IMRT and the fact that IMRT plans are
typically quality assured (QAed) by measuring the plan dose on a phantom
while 3D plans are not, we suggest that clinics who adopt the MCO-3D
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method presented herein discuss considering such plans as 3D. Our view on
this issue is that since there is a spectrum of plan complexity between 3D
conformal and IMRT, this spectrum should be realized more fully in the
clinic: a plan should be as complex as necessary to achieve a desired level
of dose quality. QA procedures should be standardized, and should take the
form of independent software – such as a Monte Carlo system – in order to
automatically verify all plans [18, 19], thus eliminating the QA distinction
between 3D and IMRT plans.
In modern clinics, IMRT has become the clinical standard for sites which
most strongly benefit from being able to shape the dose distribution to avoid
nearby OARs. However, all sites could benefit from some intensity mod-
ulation, which is why 3D conformal therapy has evolved to include FIFs,
wedges and higher energies. These advanced technologies provide dose con-
trol similar to IMRT [20]. For all of the sites studied in this paper, IMRT
has been explored [9, 21, 22, 23] and is often used, but 3D remains a com-
mon modality for treatment. One likely reason for this is that IMRT may
often seem overly complex, more costly and less efficient for the treatment
goals in mind. Our technique on the other hand depends on the idea that a
little intensity modulation goes a long way, as brought to light by the many
studies which point out the vastly diminishing returns one gets from adding
more complexity (larger MU and more segments) to a plan [24, 25, 26, 27].
Our planning method allows the customizeability and dosimetric benefits of
MCO-IMRT with the simple and robust delivery of 3D conformal therapy.
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